Cliniphar (TSE:432A) Total Equity: 円1,244 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:432A Cliniphar Ltd TSE:432A
20 GF Score
Price 円1,450.00
! 3 Warning Signs
View Full Analysis

What is Cliniphar Total Equity?

Cliniphar TSE:432A 20 Total Equity is 円1,244 Mil as of Mar. 2026. GuruFocus rates TSE:432A with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

Cliniphar's total equity for the quarter that ended in Mar. 2026 was 円1,244 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Cliniphar Total Equity Historical Data

* Premium members only.

The historical data trend for Cliniphar's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cliniphar Total Equity Chart

Cliniphar Annual Data
Trend Mar24 Mar25 Mar26
Total Equity
868.30 1,016.06 1,244.04

Cliniphar Semi-Annual Data
Mar24 Mar25 Mar26
Total Equity 868.30 1,016.06 1,244.04
TSE:432A
20GF Score
Cliniphar Ltd TSE:432A
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cliniphar Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Cliniphar's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=2600.67-1356.626
=1,244

Cliniphar's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=2600.67-1356.626
=1,244

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of 円1,244 Mil mean?
Cliniphar (TSE:432A) has a Total Equity of 円1,244 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Cliniphar and its competitors.
Is Cliniphar's Total Equity too high?
Cliniphar's current Total Equity is 円1,244 Mil. Overall, Cliniphar has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Cliniphar's Total Equity compare to competitors?
Cliniphar's Total Equity of 円1,244 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Healthcare Providers & Services company?
A good Total Equity depends on the Healthcare Providers & Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Cliniphar and its competitors. Cliniphar's current Total Equity is 円1,244 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cliniphar stock overvalued right now?
Cliniphar (TSE:432A) has a current Total Equity of 円1,244 Mil. The current Total Equity is 円1,244 Mil. Cliniphar's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Cliniphar (TSE:432A), the current Total Equity is 円1,244 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cliniphar Business Description

Address 1-7-31, Otemae, 5th Floor, OMM Building, Otemae, Chuo-ku, Osaka-shi, Osaka, JPN, 540-0008
Cliniphar Ltd is engaged in Pharmaceutical Wholesale and Distribution Business for Domestic and International Markets.
20GF Score

Get the complete analysis for TSE:432A

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,450.00
Price